Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia
Authorized Users Only
2019
Authors
Milosavljević, Filip
Vučić, M.
Manojlović, Marina

Ašujić, N.
Batinić, Bojan

Novalen, M.
Miksys, S.
Tyndale, R.F.
Ingelman-Sundberg, Magnus

Pešić, Vesna

Jukić, Marin

Conference object (Published version)

Metadata
Show full item recordSource:
European Neuropsychopharmacology, 2019, 29, Supplement 2, S672-S673Publisher:
- Elsevier Science BV, Amsterdam
Note:
- ECNP Workshop for Early Career Scientists in Europe, 7 - 10 March 2019, Nice, France
Collections
Institution/Community
PharmacyTY - CONF AU - Milosavljević, Filip AU - Vučić, M. AU - Manojlović, Marina AU - Ašujić, N. AU - Batinić, Bojan AU - Novalen, M. AU - Miksys, S. AU - Tyndale, R.F. AU - Ingelman-Sundberg, Magnus AU - Pešić, Vesna AU - Jukić, Marin PY - 2019 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3297 PB - Elsevier Science BV, Amsterdam C3 - European Neuropsychopharmacology T1 - Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia VL - 29 IS - Supplement 2 SP - S672 EP - S673 DO - 10.1016/j.euroneuro.2019.01.056 ER -
@conference{ author = "Milosavljević, Filip and Vučić, M. and Manojlović, Marina and Ašujić, N. and Batinić, Bojan and Novalen, M. and Miksys, S. and Tyndale, R.F. and Ingelman-Sundberg, Magnus and Pešić, Vesna and Jukić, Marin", year = "2019", publisher = "Elsevier Science BV, Amsterdam", journal = "European Neuropsychopharmacology", title = "Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia", volume = "29", number = "Supplement 2", pages = "S672-S673", doi = "10.1016/j.euroneuro.2019.01.056" }
Milosavljević, F., Vučić, M., Manojlović, M., Ašujić, N., Batinić, B., Novalen, M., Miksys, S., Tyndale, R.F., Ingelman-Sundberg, M., Pešić, V.,& Jukić, M.. (2019). Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia. in European Neuropsychopharmacology Elsevier Science BV, Amsterdam., 29(Supplement 2), S672-S673. https://doi.org/10.1016/j.euroneuro.2019.01.056
Milosavljević F, Vučić M, Manojlović M, Ašujić N, Batinić B, Novalen M, Miksys S, Tyndale R, Ingelman-Sundberg M, Pešić V, Jukić M. Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia. in European Neuropsychopharmacology. 2019;29(Supplement 2):S672-S673. doi:10.1016/j.euroneuro.2019.01.056 .
Milosavljević, Filip, Vučić, M., Manojlović, Marina, Ašujić, N., Batinić, Bojan, Novalen, M., Miksys, S., Tyndale, R.F., Ingelman-Sundberg, Magnus, Pešić, Vesna, Jukić, Marin, "Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia" in European Neuropsychopharmacology, 29, no. Supplement 2 (2019):S672-S673, https://doi.org/10.1016/j.euroneuro.2019.01.056 . .